Emmaceutics (Pty) Ltd is a South African pharmaceutical innovation and biotechnology company focused on translating scientific discoveries into innovative therapeutic technologies that address significant unmet healthcare needs. Founded by Emmanuel Mukisa Kiyonga, a pharmaceutical scientist, inventor and entrepreneur, Emmaceutics operates at the intersection of pharmaceutical science, drug development, materials science, biotechnology and healthcare innovation.

The organisation's core focus is the discovery, development, validation and commercialisation of novel pharmaceutical technologies

Deaf-Care Healthcare Initiative

Comprehensive Overview for the South African MedTech Innovation Challenge

1. Executive Summary

Deaf-Care Healthcare Initiative (DCHI) is a South African nonprofit company developing an innovative medical technology platform to improve healthcare access, communication, safety, and continuity of care for Deaf and Hard of Hearing people.

DCHI’s proposed solution combines a mobile medical application for Deaf and Hard of Hearing patients with secure dashboards for hospitals, clinics, emergency medical services, healthcare professionals, administrators, and qualified

The invention provides the means and the methods for the production of arrayed experiments on a substrate using the principle of a movable type printing press. This allows an entire array comprising a plurality of experiments to be printed simultaneously on a substrate. This is achieved using a...

Overview of UYR Doctors

UYR Doctors B.V. is a Netherlands-registered digital healthcare company that enables Africans in the diaspora to arrange trusted, prepaid healthcare services for their loved ones in Africa. Through the UYR Doctors mobile application, customers can book qualified doctors and nurses to provide home-based medical services, monitor the delivery of care, and receive a clinical report after each completed visit.

UYR Doctors addresses a major challenge faced by diaspora families: sending money home for healthcare does not always guarantee that the intended medical service is

VTS Technologies (Pty) Ltd is a Botswana-based technology company developing intelligent digital infrastructure that addresses complex operational challenges across Africa. Our flagship platform, GJHealth, is an AI-assisted healthcare execution infrastructure designed to strengthen healthcare delivery through clinical orchestration, telemedicine, operational awareness, medicine availability and redistribution intelligence, and interoperable healthcare coordination. The company focuses on building scalable, secure, and governance-driven enterprise platforms that support digital transformation

FutureLife Research Foundation is a Kenyan non-profit organization registered as a Company Limited by Guarantee (CLG) under the Companies Act, 2015. The Foundation was established to advance research, innovation, capacity strengthening, and sustainable development through evidence-based solutions that address pressing health, environmental, climate, and socio-economic challenges across Africa.

The Foundation works at the intersection of research, technology, and implementation science to develop, evaluate, and scale innovative solutions that improve health systems, environmental sustainability

Keloid disease is a chronic fibroproliferative skin disorder characterised by excessive scar tissue formation that extends beyond the boundaries of the original wound. Accurate diagnosis remains challenging due to the heterogeneous nature of keloids and their similarity to other fibroproliferative...

Keloid disease represents a significant and growing unmet need in dermatology and surgical care. The disease is characterised by abnormal scar formation that extends beyond the original wound site. Despite the availability of treatments such as surgery, corticosteroid injections, radiotherapy, and...

Overview of your opportunity

Applications are now open for the Merck Research Grants 2026 programme, a global research funding initiative designed to support innovative scientific research with strong potential for future impact and industry collaboration.

Since 2018, Merck has awarded research grants to scientists and research teams working on breakthrough solutions across emerging scientific and technological fields. For the 2026 funding cycle, grants are available across five strategic research areas, with funding of up to €500,000 per year available depending on the topic.

Closing date

Bloodline Medical Tech is a South African healthcare innovation company focused on improving emergency response and patient safety through rapid access to critical medical information.

Our flagship innovation, the QR-Based Blood Type Identification System, addresses a major healthcare challenge: delays in identifying patient blood types and accessing critical medical information during emergencies. In many cases, patients may be unconscious, unable to communicate, or without medical records, resulting in delays that can affect treatment outcomes.

The Bloodline system enables patients to create